Resume
Allan Henslee, PhD
PhD bioengineer. Founding employee and R&D head at iotaMotion, from company start through FDA De Novo authorization and a first-in-human trial. Since mid-2025, building production AI with Claude Code.
What I'm looking for
From early 2027, I'm looking for a full-time role at a medtech, diagnostics or health-tech company. I want to get back to building new things in healthcare, and to bring the AI systems I've been building since mid-2025 into regulated work.
- Roles
- AI, digital or data lead · product or program lead · innovation and new ventures
- Scope
- Senior hands-on role or a small team
- Where
- Austin (hybrid) or fully remote
Experience and education
2023 – present
Party On Delivery
Owner/operator; built its AI and data platform. Plus part-time AI consulting for a few outside clients (2024 – present).
2020 – 2026
NIH Center for Scientific Review
SBIR/STTR reviewer, 4 NIDCD panels, 100+ proposals
2019 – 2024
iotaMotion
Director of Research & Development
2016 – 2018
iotaMotion
Director of Product Development (founding employee)
2014 – 2016
Alcon
Business Continuity / Product Engineer
2013 – 2014
IORE
Postdoctoral researcher
2012 – 2013
Cellula Enterprises
Co-founder and CEO (Rice imaging startup)
2011 – 2012
Rice Office of Technology Transfer
Intern
2008 – 2013
Rice University
PhD, Bioengineering; managed DoD-funded (DARPA, AFIRM) research
2008
UT Austin
BS, Biomedical Engineering
Skills and record
- Medtech
- De Novo strategy · design controls · clinical study design · in vivo validation · IP · SBIR/STTR
- AI and software
- Claude Code · MCP servers · Anthropic SDK · AI agents and guardrails · Next.js and TypeScript · Postgres · Stripe · Vercel
- Record
- 21 peer-reviewed publications · co-inventor on 5 US patents (9 granted worldwide) · over $3.6M in SBIR funding as PI on four awards